Life Sciences R&D & Medical

IDC MarketScape names ZS a Leader in R&D risk-based monitoring solutions vendor assessment

March 2, 2023 | Analyst Report | 25-minute read

IDC MarketScape names ZS a Leader in R&D risk-based monitoring solutions Vendor assessment


Global clinical trial requirements increasingly emphasize a sponsor’s responsibility to identify, mitigate and manage GCP quality risk. The management of risks across a sponsor’s portfolio, processes and vendors is a complex endeavor. As a result, organizations are diligently searching for the right technology vendor to help in their risk-based quality management (RBQM).

 

“There is a need to manage risk across the quality management system (QMS), moving down the pyramid from an organizational level, looking across critical processes and critical data points, managing vendor oversight as well, and drilling down further to a portfolio, asset, study, and at a site level,” notes the latest “IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment.”

 

Considering the Food and Drug Administration’s (FDA) updated guidelines giving more importance to the entire QMS, IDC MarketScape recently assessed eight life sciences vendors in risk-based monitoring. Vendors whose services “must have been significantly evaluated for the potential to engage clients within the target IDC MarketScape space” were considered in the study. In its assessment, IDC MarketScape placed ZS in the Leaders category, citing its confluence of consulting, technology and operations resulting in a complete solution that enables RBQM at the study and enterprise level. According to the report, “Consider ZS when seeking a customized technology platform and consulting capabilities to enable enterprise-wide portfolio and study-level performance, build strategy to bring oversight to QMS processes, deep expertise on RBQM and change management, as well as CM services.”

 

Get your complimentary access to an excerpt of the “IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment” to see why ZS was named a Leader.

Source: “IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment," By: Nimita Limaye, November 2022, IDC # US48061722.

IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. The Capabilities score measures vendor product, go-to-market and business execution in the short-term. The Strategy score measures alignment of vendor strategies with customer requirements in a 3-5-year timeframe. Vendor market share is represented by the size of the circles. Vendor year-over-year growth rate relative to the given market is indicated by a plus, neutral or minus next to the vendor name. 

Add insights to your inbox

We’ll send you content you’ll want to read – and put to use.